“…In the past decades, drug-carrying nanomaterials, such as hydrogels, , peptides, , metal NCs, − and carbon-based quantum dots, have attracted wide attention and demonstrated the validity in improving the pharmacokinetics and biodistribution by protecting their active cargo from degradation and promoting its effective release and therapy efficiency to cancer cells. − Comparatively, hydrophilic metal NCs are much more suitable for drug delivery purposes due to their nontoxicity, ultrasmall size, strong PL, high penetration capability, and good pharmacokinetics similar to those of small molecules in vivo . However, many metal NCs usually suffer from a low stability of physicochemical properties in vivo , limiting their practical application in clinical therapy .…”